Working... Menu
Trial record 42 of 44 for:    "porphyria"

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01097044
Recruitment Status : Completed
First Posted : April 1, 2010
Last Update Posted : March 25, 2013
Information provided by (Responsible Party):
Clinuvel Pharmaceuticals Limited

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : April 2011
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 August 14, 2018
September 14, 2018